Patents Assigned to Moderna Enzymatics Co., Ltd.
  • Patent number: 11685940
    Abstract: Provided is a method capable of replicating or amplifying circular DNA, and particularly, long-chain circular DNA, in a cell-free system. Specifically, provided is a method for suppressing generation of a DNA multimer as a by-product, when circular DNA having a replication origin sequence (origin of chromosome (oriC)) is replicated or amplified by using the following enzyme groups: (1) a first enzyme group that catalyzes replication of circular DNA; (2) a second enzyme group that catalyzes an Okazaki fragment maturation and synthesizes two sister circular DNAs constituting a catenane; and (3) a third enzyme group that catalyzes a separation of two sister circular DNAs. Moreover, also provided is a method comprising introducing oriC into circular DNA by using a transposon.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: June 27, 2023
    Assignee: Moderna Enzymatics Co., Ltd.
    Inventors: Masayuki Su'etsugu, Seia Nara